Azithromycin Dosing in Enteric Fever
For uncomplicated enteric fever in adults and children, azithromycin should be dosed at 20 mg/kg/day (maximum 1000 mg/day) orally for 5-7 days, with 7 days preferred for optimal outcomes. 1, 2, 3, 4
Recommended Dosing Regimens
Adults
- Oral: 20 mg/kg/day (maximum 1000 mg/day) for 7 days 4
- Alternative loading approach: 1000 mg on day 1, followed by 500 mg daily for 5-6 additional days 5
- Intravenous (when oral not possible): 500 mg IV daily, followed by oral therapy to complete 7-day course 6
Children
- Oral: 20 mg/kg/day (maximum 1000 mg/day) for 5-7 days 1, 3, 4
- The 7-day regimen is superior to 5-day courses based on comparative efficacy data 4
Evidence Supporting 7-Day Duration
The most robust comparative trial demonstrated that 7-day azithromycin courses achieved 82% clinical cure rates versus 64% with fluoroquinolones in multidrug-resistant (MDR) and nalidixic acid-resistant typhoid 4. This study showed significantly shorter fever clearance times (5.8 days versus 8.2 days) and dramatically lower post-treatment fecal carriage (1.6% versus 19.4%) with azithromycin 4. While 5-day courses showed 94-95% cure rates in earlier studies 2, 3, the 7-day regimen provides more consistent outcomes across different resistance patterns.
Intravenous Administration
When oral intake is not feasible:
- Dose: 500 mg IV as single daily infusion 6
- Concentration and rate: Either 1 mg/mL over 3 hours OR 2 mg/mL over 1 hour 6
- Duration: Continue IV for 1-2 days minimum, then switch to oral (500 mg daily) when clinically appropriate to complete 7-day total course 6
- Critical: Never administer as bolus or intramuscular injection 6
Hepatic Impairment Adjustments
No dose adjustment is required for mild-to-moderate hepatic impairment (Child-Pugh Class A or B). Pharmacokinetic studies demonstrated that azithromycin elimination half-life increased only modestly from 53.5 hours in healthy subjects to 60.6 hours (Class A) and 68.1 hours (Class B), with similar AUC values across groups 7. However, exercise caution in severe hepatic impairment as pharmacokinetics have not been established in this population 6, 7.
Renal Impairment
No dose adjustment needed for any degree of renal impairment, including severe dysfunction (GFR <10 mL/min) 6. While AUC increases 35% in severe renal impairment, this does not warrant dose modification 6.
Clinical Considerations and Pitfalls
Resistance Patterns
All recent studies confirm 100% susceptibility of Salmonella Typhi and Paratyphi A to azithromycin despite widespread fluoroquinolone resistance 8, 9. MIC values typically range 4-8 mcg/mL, well below susceptibility breakpoints 2, 5, 10.
Pharmacokinetic Reality
Despite low plasma concentrations (Cmax 0.24-1.24 mg/L), azithromycin achieves >1000-fold higher concentrations in leukocytes and extensive tissue distribution 6, 10. This explains clinical efficacy despite plasma levels below MIC values 10.
Treatment Failure Indicators
Expect fever clearance within 3-6 days 4, 8, 10. Prior antibiotic therapy, splenomegaly, and systemic complications significantly delay defervescence 8. If fever persists beyond 5-7 days, consider:
- Treatment failure (rare with azithromycin)
- Complications requiring drainage
- Alternative diagnosis
Common Errors to Avoid
- Do not use 3-day courses - insufficient for enteric fever despite effectiveness in other infections
- Do not combine with fluoroquinolones routinely - combination therapy showed no advantage over azithromycin alone 4
- Do not withhold treatment pending susceptibility - resistance to azithromycin remains virtually absent 9, 11
Special Populations
For pregnant women, azithromycin is FDA Pregnancy Category B and preferred over fluoroquinolones 12. The standard 7-day regimen applies without modification.